Radovan Vasic

476 total citations
8 papers, 124 citations indexed

About

Radovan Vasic is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Radovan Vasic has authored 8 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Hematology and 2 papers in Cancer Research. Recurrent topics in Radovan Vasic's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer-related gene regulation (2 papers). Radovan Vasic is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer-related gene regulation (2 papers). Radovan Vasic collaborates with scholars based in United States, Canada and China. Radovan Vasic's co-authors include Stephanie Halene, Toshihiko Oki, Peter R. Swiatek, Vionnie W.C. Yu, David T Scadden, Stefania Lymperi, Francesca Ferraro, Alexandra M. E. Jones, Kai Rejeski and Yuanbin Song and has published in prestigious journals such as Blood, Leukemia and Stem Cell Reports.

In The Last Decade

Radovan Vasic

8 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radovan Vasic United States 4 84 60 33 23 16 8 124
Jenny Li United States 4 45 0.5× 55 0.9× 20 0.6× 32 1.4× 14 0.9× 7 108
Inge van der Werf Netherlands 7 124 1.5× 46 0.8× 37 1.1× 18 0.8× 20 1.3× 17 168
Bettina Moehrle Germany 4 68 0.8× 63 1.1× 17 0.5× 35 1.5× 15 0.9× 5 127
Shanisha Gordon-Mitchell United States 2 97 1.2× 98 1.6× 23 0.7× 55 2.4× 33 2.1× 5 165
Patee Gesuwan United States 4 68 0.8× 93 1.6× 45 1.4× 11 0.5× 12 0.8× 7 121
Konstanze Doehner Germany 4 68 0.8× 41 0.7× 12 0.4× 14 0.6× 13 0.8× 14 101
Aron Skaftason Sweden 5 44 0.5× 50 0.8× 24 0.7× 12 0.5× 9 0.6× 7 84
Ahmad S. Zebari United States 3 191 2.3× 84 1.4× 29 0.9× 14 0.6× 27 1.7× 5 216
Charles Dussiau France 7 51 0.6× 40 0.7× 13 0.4× 29 1.3× 19 1.2× 11 101
Aisha Jibril United Kingdom 5 50 0.6× 36 0.6× 33 1.0× 38 1.7× 7 0.4× 11 108

Countries citing papers authored by Radovan Vasic

Since Specialization
Citations

This map shows the geographic impact of Radovan Vasic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radovan Vasic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radovan Vasic more than expected).

Fields of papers citing papers by Radovan Vasic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radovan Vasic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radovan Vasic. The network helps show where Radovan Vasic may publish in the future.

Co-authorship network of co-authors of Radovan Vasic

This figure shows the co-authorship network connecting the top 25 collaborators of Radovan Vasic. A scholar is included among the top collaborators of Radovan Vasic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radovan Vasic. Radovan Vasic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Mercier, François, Jiantao Shi, David B. Sykes, et al.. (2022). In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies. Blood Advances. 6(17). 5072–5084. 11 indexed citations
2.
Gao, Yimeng, Joshua T. Zimmer, Radovan Vasic, et al.. (2021). ALKBH5 Modulates Hematopoietic Stem and Progenitor Cell Energy Metabolism through m 6a Modification-Mediated RNA Stability. Blood. 138(Supplement 1). 298–298. 1 indexed citations
3.
Vasic, Radovan, et al.. (2020). The Role of RNA Epigenetic Modification in Normal and Malignant Hematopoiesis. Current Stem Cell Reports. 6(4). 144–155. 12 indexed citations
4.
Liang, Yang, Toma Tebaldi, Kai Rejeski, et al.. (2018). SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells. Leukemia. 32(12). 2659–2671. 57 indexed citations
5.
Gao, Yimeng, Radovan Vasic, Toma Tebaldi, et al.. (2018). Mettl3 Mediated m6A Modification Is Essential in Fetal Hematopoiesis. Blood. 132(Supplement 1). 3825–3825. 3 indexed citations
6.
Yu, Vionnie W.C., Stefania Lymperi, Toshihiko Oki, et al.. (2016). Distinctive Mesenchymal-Parenchymal Cell Pairings Govern B Cell Differentiation in the Bone Marrow. Stem Cell Reports. 7(2). 220–235. 38 indexed citations
7.
Liang, Ying, Gerrit M. Daubner, Giovanni Stefani, et al.. (2015). 22 MUTATIONS IN SRSF2 IDENTIFIED IN MYELODYSPLASIA AFFECT RNA BINDING AFFINITY, SPECIFICITY, AND SPLICING. Leukemia Research. 39. S9–S10. 1 indexed citations
8.
Sáez, Borja, Francesca Ferraro, Rushdia Z. Yusuf, et al.. (2012). Hematopoietic Stem/Progenitor Cell Retention in the Bone Marrow Depends On Tissue Specific Heparan Sulfate Proteoglycans. Blood. 120(21). 637–637. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026